<DOC>
	<DOCNO>NCT00658203</DOCNO>
	<brief_summary>The aim study compare clinical benefit cardiac resynchronisation ( CRT ) achieve PEA optimise pace configuration CRT optimise standard clinical procedure . PEA optimise configuration ( PEA-CRT ) obtain , patient 's follow-up , use Peak Endocardial Acceleration sensor feature onboard device .</brief_summary>
	<brief_title>Clinical Evaluation Advanced Resynchronization</brief_title>
	<detailed_description>The study prospective , multicentre , control randomised clinical investigation , two single-blinded arm . The objective study compare clinical benefit Cardiac Resynchronisation Therapy ( CRT ) optimise automatic PEA sensor feature ( PEA-CRT ) , obtain standard optimisation procedure ( STD-CRT ) . The patient candidate inclusion study severe chronic Heart Failure , indicate implantation Biventricular pacing system accord updated ESC guideline ( 2005 ) . All patient include study followed-up 1 year ; patient 's follow-up schedule hospitalisation , one month , 3 month , 6 month one year implantation .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>The patient candidate inclusion study must indicate implantation Biventricular pacing system , follow clinical condition : Severe Heart Failure ( NYHA Class III IV ) Cardiomyopathy etiology Sinus rhythm Reduced LeftVentricular Ejection Fraction LeftVentricular End Diastolic Diameter great equal 30 mm/m2 ( LVEDD &gt; 30 mm/m2 ) QRS Duration : &gt; 150 m &gt; 120 m document Mechanical Dissynchrony ( ECHO ) meeting two three follow criterion : Aortic PreEjection Delay &gt; 140 m Interventricular Mechanical Delay &gt; 40 m Delayed activation posterolateral Left Ventricular wall ( mitral valve open ) Optimal stable ( 1 month inclusion ) pharmacological treatment , include , tolerate , Beta Blockers , AngiotensinConverting Enzyme ( ACE ) Inhibitors ACE Inhibitor substitute , Spironolactone , diuretics Any patient one follow characteristic exclude study : ICD indication ( Lifethreatening ventricular arrhythmia ) Persistent permanent Atrial Arrhythmia without possibility restore sinus rhythm ( spontaneous termination , antitachycardia pacing , pharmacological electrical cardioversion ) . Patient already implant conventional pacemaker device Myocardial infarction within last three month Heart surgery , revascularization within last three month , expect Heart surgery refuse comorbidity factor Included transplantation list Already enrol study Life expectancy less 1 year Pregnancy Age less 18 Forfeiture freedom guardianship Not able understand aim study procedure Refusing cooperate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>CRT-P</keyword>
	<keyword>PEA</keyword>
	<keyword>Severe Heart Failure ( NYHA Class III IV )</keyword>
	<keyword>Cardiomyopathy etiology</keyword>
	<keyword>Sinus rhythm</keyword>
	<keyword>Reduced Left-Ventricular Ejection Fraction</keyword>
	<keyword>LVEDD &gt; 30 mm/m2</keyword>
	<keyword>QRS Duration : &gt; 150 m &gt; 120 m</keyword>
	<keyword>Aortic Pre-Ejection Delay &gt; 140 m</keyword>
	<keyword>Interventricular Mechanical Delay &gt; 40 m</keyword>
	<keyword>Delayed activation postero-lateral Left Ventricular wall</keyword>
	<keyword>Optimal stable pharmacological treatment</keyword>
</DOC>